ATH alterity therapeutics limited

Ann: Prana provides regulatory update for PBT2-PBT.AX, page-8

  1. 7,425 Posts.
    lightbulb Created with Sketch. 125
    I think when we get PBT2 to European market, patients will fly over for their supplies to buy them in Europe...we really do not need USA market to treat Huntington patients base....we just need to be IN the market....any market....even I can see that!...and when our treatment becomes really successful one, the pressure from USA Huntington group may force the FDA to make it available in USA...
    feeling a bit more positive after reading the ann today.....do not even care that market punished us with a further drop in sp.....this is its way of saying what they think of that stalemate....and someones incompetence.....
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.6¢
Change
0.001(6.67%)
Mkt cap ! $147.3M
Open High Low Value Volume
1.5¢ 1.7¢ 1.5¢ $770.2K 49.71M

Buyers (Bids)

No. Vol. Price($)
8 2038332 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 349000 2
View Market Depth
Last trade - 16.10pm 25/07/2025 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.